Agenda
9:00 AM — 5:00 PM
Short Course 1: Introduction to Pharmacoepidemiology9:00 AM — 5:00 PM
Short Course 2: Pharmacovigilance and Risk Management Planning9:00 AM — 12:30 PM
Short Course 3: Reference Safety Information12:30 PM — 1:30 PM
1:30 PM — 5:00 PM
Short Course 4: Combination Therapies7:15 AM — 8:15 AM
7:30 AM — 5:30 PM
8:00 AM — 8:15 AM
8:15 AM — 8:30 AM
Welcome Remarks8:30 AM — 9:00 AM
Opening Keynote9:00 AM — 10:15 AM
Session 1: FDA Updates10:15 AM — 10:45 AM
10:45 AM — 12:15 PM
Session 2: Patient Perspectives on the Risks and Benefits of Opioid Therapy12:15 PM — 1:30 PM
1:30 PM — 2:15 PM
Session 3: Rare Disease I2:15 PM — 3:00 PM
Session 4: Rare Disease II: The Patient Story3:00 PM — 3:30 PM
5:00 PM — 7:00 PM
DIA 2019 Program Launch and Networking and Exhibits Reception7:30 AM — 8:30 AM
7:30 AM — 6:00 PM
8:30 AM — 8:45 AM
8:45 AM — 10:00 AM
Session 6: EU Updates10:00 AM — 10:30 AM
12:00 PM — 1:30 PM
1:30 PM — 3:00 PM
Session 8: ABSTRACT SESSION3:00 PM — 3:30 PM
3:30 PM — 4:30 PM
Session 9: Reference Safety Information Use in Clinical Trials7:15 AM — 8:15 AM
7:15 AM — 3:00 PM
8:15 AM — 8:30 AM
8:30 AM — 10:00 AM
Session 10: Emerging Regions Issues10:00 AM — 10:30 AM
10:30 AM — 11:30 AM
Session 11: Immuno-oncology – The benefits and the Safety Challenges11:30 AM — 1:00 PM
2:30 PM — 3:00 PM
3:00 PM — 4:15 PM
Session 13: Aspects of Benefit-Risk Assessments4:15 PM — 5:00 PM
Session 14: Hot Topics5:00 PM — 5:15 PM
Have an account?